Bioworkshops sell "Nivolumab"
Basic Information
357
15
4
4.1(28)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Nivolumab
Manufacturer(s)
Specifications
- Expression System: mAb (CAS 946414-94-4) developed from a DMF-filed cell line, targeting PD-1.
- Regulatory Status: Approved 04/07/2014 in Japan; representative indications include esophageal carcinoma and melanoma.
- Purity: High degree of analytical similarity to the reference product, produced via an optimized, high-titer cell line and process.
Documents
GMP
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment